Health-related Quality of Life of Bone Marrow versus Peripheral Blood Stem Cell Donors: A Prespecified Subgroup Analysis from a Phase III RCT—BMTCTN Protocol 0201
Galen E. Switzer(University of Pittsburgh), John R. Wingard(University of Florida Health), Rebecca Drexler(National Marrow Donor Program), Jessica G. Bruce(University of Pittsburgh), Claudio Anasetti(Moffitt Cancer Center), Scott D. Rowley(Johns Hopkins Hospital), Michael Haagenson(National Marrow Donor Program), Susan F. Leitman(Beverly Hospital), Paolo Anderlini(The University of Texas MD Anderson Cancer Center), Dennis L. Confer(National Marrow Donor Program), Amy Foley(National Marrow Donor Program), Donna J. Harrington(University of Pittsburgh)
Cited by 37
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k